Loading...
XASX
EVE
Market cap2mUSD
Oct 09, Last price  
0.02AUD
1D
0.00%
1Q
-11.76%
Jan 2017
87.50%
IPO
-7.41%
Name

Eve Health Group Ltd

Chart & performance

D1W1MN
XASX:EVE chart
P/E
—
P/S
2.94
EPS
—
Div yield, %
—
Shrs. gr., 5y
-42.37%
Rev. gr., 5y
-16.26%
Revenues
1m
-33.53%
0000006,8020198-13824518,9041,598,0002,311,0002,801,0002,009,0002,331,0002,134,0001,734,7261,153,101
Net income
-2m
L+19.67%
-2,655,000-3,001,000-3,600,000-3,387,00021,221,000-5,199,000-17,384,000-386,681-7,368,000-1,104,000-1,387,000-1,880,000-2,639,000-2,400,000-3,631,000-5,372,000-4,044,000-1,901,000-1,579,955-1,890,753
CFO
-2m
L+7.80%
-1,369,595-2,517,781-2,905,598-2,256,822-5,003,583-1,578,6150-157,195-240,463-645,763-558,994-808,760-1,071,136-3,155,926-2,244,044-3,771,777-1,649,087-1,106,964-1,615,537-1,741,571

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Based in Subiaco, Australia, Eve Health Group Limited, originally incorporated in 2003 as EVE Investments Limited, is an international provider of health, wellness, and nutritional products. The company operates across Australia, New Zealand, the Asia Pacific region, and North America. Its activities include the production of organic tea tree oils, the distribution of botanical oils, and the supply of a wide array of other oils such as essential oils, hydrosols, extracts, carrier oils, and seed oils. Furthermore, Eve Health Group offers organic raw honey and raw honey probiotic concentrates, alongside contract manufacturing services. A key area of its focus is developing medical nutrition solutions for chronic and lifestyle ailments, exemplified by Gluco Smooth, a product designed to help manage type 2 diabetes by moderating post-meal blood sugar levels, as well as providing various dietary intervention programs.

Key people

Rodney Hannington
Non-Executive Chairman of the Board · since 2025
Ben Rohr
Chief Operating Officer · since 2019
Damian Wood
Chief Executive Officer, Managing Director · since 2025
Steven Jackson
Company Secretary · since 2012
Stuart Gunzburg
Director · since 2025
Non-Executive Director · since 2025
Carlos Jin
Non-Executive Director · since 2019
James Lin
Non-Executive Director · since 2021
IPO date
Apr 08, 2004
Employees
Domiciled in
AU
Incorporated in
AU

Valuation

Title
AUD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2026‑062025‑062024‑062023‑062022‑062021‑062020‑062019‑062018‑062017‑06
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT